July 15, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · DOI: 10.1200/JCO-25-02520

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848

Listen to this summary

The authors aimed to determine whether adding fluoropyrimidine sensitized radiotherapy (CXRT) to adjuvant chemotherapy improves overall survival (OS) in patients with adenocarcinoma of the pancreatic head after curative resection. The study found that while CXRT did not significantly enhance OS or disease-free survival (DFS) for the overall population, it showed a beneficial effect on OS and DFS in node-negative patients, suggesting a potential role for CXRT in this subgroup.

Ross A Abrams, Kathryn A Winter, Karyn A Goodman, William F Regine, Howard P Safran, Chandan S Guha, Lisa A Kachnic, Michael T Gillin, Philip A Philip, Andrew M Lowy, Eileen O'Reilly, Jean-Luc Van Laethem, Samantha A Seaward, Abraham J Wu, Jennifer J Wu, Raid M Aljumaily, Thomas A DiPetrillo, Ravit Geva, Pramila Rani Anne, Darla K Liles, Diane C Ling, Alison Conlin, Jennifer Moughan, Christopher H Crane

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play